GeneCapture: Funding, Investors & Team (Nov 2026)
GeneCapture is a biotechnology company that develops a rapid point of care diagnostic for detecting infections. GeneCapture's unique approach to disease diagnostics uses rapid RNA-based technology to bring infection detection to the Point of Care; whether that’s a hospital bed, an airport, a cruise ship, or a battlefield. Using direct RNA hybridization and optical sensing, our validated pathogen detection, and antibiotic sensitivity test provides rapid results for on-site, real-time decision making. The company was founded in 2009 and is based in Huntsville, Alabama.
GeneCapture has raised $1.2M across 1 funding round on record, the most recent an undisclosed round of $1.2M announced in Sep 2021.
That round is below the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GeneCapture Company Profile and Key Stats
Latest funding round on record: Sep 2021.
GeneCapture Funding Rounds
GeneCapture Founders and Leadership Team
Contact details for the GeneCapture team: 1 of 1 has an email address on file.
Start 14-day free trial →GeneCapture Funding Compared to Other Biotechnology Startups
GeneCapture's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GeneCapture in Biotechnology and Huntsville
Companies Similar to GeneCapture
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
GeneCapture Funding FAQs
What does GeneCapture do?
GeneCapture is a biotechnology company that develops a rapid point of care diagnostic for detecting infections. GeneCapture's unique approach to disease diagnostics uses rapid RNA-based technology to bring infection detection to the Point of Care; whether that’s a hospital bed, an airport, a cruise ship, or a battlefield. Using direct RNA hybridization and optical sensing, our validated pathogen detection, and antibiotic sensitivity test provides rapid results for on-site, real-time decision making. The company was founded in 2009 and is based in Huntsville, Alabama.
How much funding has GeneCapture raised?
GeneCapture has raised $1.2M across 1 round on record. The most recent is an undisclosed round of $1.2M announced in Sep 2021.
When did GeneCapture last raise funding?
GeneCapture's most recent funding round on record is an undisclosed round of $1.2M, announced in Sep 2021.
Who is the CEO of GeneCapture?
Peggy Sammon is listed as CEO at GeneCapture.
Where is GeneCapture headquartered?
GeneCapture is based in Huntsville, Alabama, United States.
How many employees does GeneCapture have?
GeneCapture is in the 11-50 employee band.
How does GeneCapture's funding compare to other Biotechnology startups?
GeneCapture's latest round of $1.2M is below the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's GeneCapture Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GeneCapture is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.